Our work is devoted to precision medicine in the field of transplantation from the perspective of the gut microbiome. We are involved in several projects investigating the consequences of chronic dysbiosis on transplant outcomes. We target the gut microbiome to prevent immunosuppressive drugs side effects and to study the link between graft rejection and chronic dysbiosis.